Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

In terms of liquidity and interest, the mean open interest for McKesson options trades today is 166.17 with a total volume of ...

McKesson (MCK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Investors in McKesson MCK need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 15, 2024 $270.00 Call had some of the highest implied volatility ...

Integrated Advisors Network LLC lowered its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 3.9% in the 3rd quarter, according to its most recent disclosure with the Securities & ...

They warehouse name-brand drugs, generic drugs, and medical/surgical supplies, getting them to ... and development to produce new drugs. McKesson partners with biopharma companies, care providers ...

Arkadios Wealth Advisors boosted its stake in McKesson Co. (NYSE:MCK – Free Report) by 43.7% in the 3rd quarter, according to ...

McKesson (MCK) closed the latest trading ... incorporates the company's anticipated earnings growth rate. The Medical - Dental Supplies was holding an average PEG ratio of 1.83 at yesterday's ...

McKesson (MCK) closed the most recent trading day at $499.34, moving +0.03% from the previous trading session. The stock's change was more than the S&P 500's daily loss of 0.33%. Meanwhile, the Dow ...

McKesson (MCK) closed at $488.78 in the ... incorporates the company's anticipated earnings growth rate. The Medical - Dental Supplies was holding an average PEG ratio of 1.81 at yesterday's ...

Barclays analyst Stephanie Davis maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $616.00. The ...

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.